KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation-Reference-Cited by-同舟云学术

KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation

Published:2022-12-05 Issue:3 Volume:62 Page:303-318
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Molecular Carcinogenesis

Author:

Zhang Jun¹,An Lanfen²,Zhao Rong¹,Shi Rui¹,Zhou Xing¹,Wei Sitian¹,Zhang Qi¹,Zhang Tangansu¹,Feng Dilu¹,Yu Zhicheng¹,Wang Hongbo¹³^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China

2. Division of Life Science and Medicine, Clinical Center of Reproductive Medicine, The First Affiliated Hospital of USTC University of Science and Technology of China Hefei China

3. Clinical Research Center of Cancer Immunotherapy Wuhan Hubei China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23487

Reference67 articles.

1. Endometrial cancer

2. Cancer of the corpus uteri

3. Two pathogenetic types of endometrial carcinoma

4. Treatment strategies for endometrial cancer: current practice and perspective

5. Clinical actionability of molecular targets in endometrial cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WZ-3146 acts as a novel small molecule inhibitor of KIF4A to inhibit glioma progression by inducing apoptosis;Cancer Cell International;2024-06-27

2. Independent organelle and organelle—organelle interactions: essential mechanisms for malignant gynecological cancer cell survival;Frontiers in Immunology;2024-04-22

3. A Novel KIF4A-Related Model for Predicting Immunotherapy Response and Prognosis in Kidney Renal Clear Cell Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-02-14

4. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA;Redox Biology;2024-02

5. Verteporfin suppressed mitophagy via PINK1/parkin pathway in endometrial cancer;American Journal of Cancer Research;2024